Use of sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (HCC) appears to be effective, but the beneficial effect on survival is lost when the drug is used as a second-line or adjuvant therapy, a study has found.
The regular use of aspirins and direct-acting oral anticoagulants (DOAC) lowers the positive predictive value of the faecal immunochemical test in screening for colorectal cancer, a recent study has found.
Leuprolide acetate 22.5 mg, a novel 3-month depot formulation, is well tolerated and proves effective in achieving and maintaining testosterone concentration below castration levels in patients with prostate cancer, according to the results of a phase III trial.
Use of antitumour necrosis factor (anti-TNF) therapy appears to protect against the risk of intestinal surgery among patients with inflammatory-type Crohn’s disease (CD) at the initial diagnosis, a study has found.
Use of budesonide orodispersible tablet in the treatment of adult patients with eosinophilic oesophagitis is safe and effective, inducing clinical and histologic remission, according to the results of a phase III trial.
Extended treatment with intermittent administration of letrozole among postmenopausal women with hormone receptor-positive breast cancer results in less symptom worsening during the first year compared with continuous endocrine therapy, results of the SOLE quality of life (QOL) sub-study have shown.
Interrupting intravenous infusions for at least 4 weeks prior to hip and knee arthroplasty does not improve postoperative outcomes, such as hospitalized infection, prosthetic joint infection and readmission, according to a recent study.
A recent survey with patients taking chronic antithrombotic medications has shown that timeliness, accuracy and adaptiveness to prior patient experiences while offering a single, consistently available point of contact are deemed necessary to enhance the communication process in periprocedural antithrombotic medication management.
Diagnosis of polycystic ovary syndrome (PCOS) is challenging, and there should be no rush to label an adolescent as having the condition before a thorough evaluation of symptoms, according to a leading endocrinologist who was speaking at the RCOG World Congress 2018 in Singapore.
Patients on the anticoagulant drug edoxaban could safely continue their treatment while undergoing certain procedures, with a low incidence of bleeding and cardiovascular events reported in the prospective EMIT AF/VTE* study.